Related Experiment Video
Updated: Jul 28, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Radiation modifiers: treatment overview and future investigations
C T Thomas1, A Ammar, J J Farrell
1Department of Radiation Oncology, David Geffen School of Medicine at University of California Los Angeles, 200 Medical Plaza, Suite B265, Los Angeles, CA 90095, USA.
Hematology/Oncology Clinics of North America
|April 4, 2006
Summary
New targeted therapies combined with radiation sensitizers need further evaluation for clinical utility and radiation effects. Free radical scavengers show potential as radioprotectors but lack convincing mucoprotection data.
Area of Science:
- Radiation oncology
- Medical physics
- Pharmacology
Background:
- Radiosensitizers are established in clinical practice.
- Novel targeted therapies interacting with radiation are under development.
- Understanding combined therapy effects and radiation toxicity is crucial.
Purpose of the Study:
- To evaluate the clinical utility of new targeted therapies with radiation sensitizers.
- To assess acute and late radiation effects of combined treatments.
- To explore the role of free radical scavengers in radioprotection and mucoprotection.
Main Methods:
- Clinical trials evaluating targeted therapies.
- Preclinical studies on radiation-drug interactions.
- Analysis of existing literature on radiosensitizers and radioprotectors.
Main Results:
- The clinical utility of targeted therapies combined with radiation sensitizers requires further investigation.
- Data on acute and late radiation effects for these combinations are needed.
- Free radical scavengers show promise for radioprotection, but evidence for mucoprotection is limited.
Conclusions:
- Further research is essential to integrate novel targeted therapies with radiation sensitizers effectively.
- Comprehensive evaluation of radiation-induced toxicities is necessary.
- Targeted approaches for radioprotection and mucoprotection warrant continued investigation.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...